Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 12.97% vs 7.40% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 20.68% vs 41.63% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 7.05% vs 10.69% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -4.17% vs -19.36% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of ERIS Lifescience With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 15.42% vs -6.30% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 12.97% vs 7.40% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -49.44% vs 182.40% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 20.68% vs 41.63% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 8.28% vs -2.86% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 7.05% vs 10.69% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 2.26% vs -6.55% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -4.17% vs -19.36% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






